Longwood Fund II, L.P. insider trades: Flex Pharma (FLKS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Longwood Fund II, L.P. reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 16, 2018 | FLKS | ↓ Sell | 3,212,861 | $0.92 | $2.9M | Direct | Oct 18, 2018 (2d) |
| Mar 11, 2016 | FLKS | ↑ Buy | 89,680 | $7.00 | $628K | Direct | Mar 15, 2016 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Longwood Fund II, L.P.'s insider trades
Longwood Fund II, L.P. is a 10% owner of Flex Pharma (FLKS). Since Mar 11, 2016, it has reported 1 open-market purchase worth $628K and 1 sale worth $2.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FLKS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.